5/14/2021Antengene Announces the IND Approval for Eltanexor in Patients with Ad...

5/14/2021CDE Solicits Comments on the Guidelines for Clinical Trial of Therapeu...

5/14/2021CDE Solicits Comments on the Guidelines for Writing Relevant Pediatric...

5/14/2021PharmaDJ's China Market Approval Tracker: March 2021

5/13/2021Antengene Granted Chinese IND Approval for a Global PIII Trial of Sel...

5/13/2021China Inaugurates State Administration of Disease Prevention and Contr...

5/13/2021NMPA Issues the Guidelines for Pharmacovigilance Quality Control

5/13/2021NHC Issues the 2021 Edition of Diagnostic and Therapeutic Guidelines f...

5/12/2021GlobalData: New Chinese Breakthrough Therapy Designation Attracts Fore...

5/12/2021CDE Solicits Comments on the Guidelines for Clinical Trial Protocol De...

5/12/2021IQVIA: Chinese Hospital Drug Market Down 10.7% in 2020

5/12/2021Citrine and Diurnal Enter Partnership to Pring Efmody to China for...

5/12/2021Pharma e-Commerce Operator Beijing Yuanxin Eyes HK IPO

5/11/2021Sumitomo Dainippon and Sinovant Enter License Pact for Select Asian Pr...

5/11/2021Shanghai-based Alebund Pharma Raises $60M in Series B Financing Round

5/11/2021AmCham White Paper Calls on China to Play Fair

5/11/2021Nanobiotix and LianBio Tie Up for First-in-Class Radioenhancer NBTXR3 ...

5/11/2021China's Population Growth Closer to Zero

5/11/2021IQVIA's New Report: Global Medicine Spending and Usage Trends: Outlook...

5/11/2021Nature: Characteristics of Expedited Programmes for Cancer Drug Approv...

5/10/2021Fosun and BioNTech to Form JV for Chinese Production of mRNA Vaccines

5/10/2021State Council Issues New Policy Document on Boosting Drug Regulatory C...

5/10/2021NHSA and NHC Issues Policy Document for "Twin-Channel" Mechanism of Ne...

5/10/2021ECI and Qilu Pharma Signs Agreement to Be Exclusive U.S. Distributor o...

5/8/2021WHO Approves China's Sinopharm Vaccine for Emergency Use

5/8/2021Amphastar to Restructure Its Chinese Subsidiaries

5/8/2021JPO Officially Initiates Information Submission for the 5th Round of N...

5/7/2021BeiGene Secures Chinese Approval of PARP Inhibitor Pamiparib

5/7/2021Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Comb...

5/7/2021WuXi Biologics Completed Three Acquisitions to Enhance its Global Netw...

Page:187/775 Total number of articles:23222: [First][<<] [185] [186] [187] [188] [189] [>>] [End]